HC Deb 30 October 1992 vol 212 cc941-2W
Mr. Redmond

To ask the Secretary of State for Health (1) if she will list, for the last 12 months, the titles of papers published by the chief executive of each executive agency for which she is responsible;

(2) if he will list the fact-finding visits made in the last 12 months by the chief executive of each executive agency for which he is responsible; and what were the findings resulting from each visit.

Dr. Mawhinney

The administration of the Medicines Control Agency is a matter for the chief executive, Dr. Keith Jones, and the administration of the National Health Service Estates Agency is a matter for its chief executive, Mr. J. C. Locke. I have asked the chief executives to reply to the hon. Member.

Letter from L. John Wardle to Mr. Martin Redmond, dated 30 October 1992: The Secretary of State for Health has advised that two of your recent parliamentary questions will be answered directly by the Chief Executive of the relevant agencies. In the absence of our Chief Executive this week, I give below the response for NHS Estates. Parliamentary Question PQ 1430 None of the visits made by the Chief Executive during the past twelve months were arranged specifically for fact finding purposes. However, various meetings with senior NHS managers have provided information which will help the Agency meet the needs of its customers in the most effective and efficient way. Parliamentary Question PQ 1380 During the past 12 months the Chief Executive has published an Annual Report and Accounts. The Agency has also published a number of guidance documents on the safe design, operation and management of the health care estate as shown in the accompanying table.

NHS ESTATES—GUIDANCE DOCUMENTS

Publications in 12 months to October 1992

Design Guides

  • The design of community hospitals
  • The design of day nurseries in a DGH

Estatecode

  • Level 2—Estate management information in the NHS

Firecode

  • Fire Practice Note 5—Commercial enterprises on hospital premises

Health Building Notes

  • 8—Rehabilitation—accommodation for physioth-eraphy occupational therapy and speech therapy
  • 15—Accommodation for pathology services
  • 18—Office accommodation in health buildings
  • 20—Mortuary and post-mortem room
  • 26—Operating department
  • 34—Estate maintenance and works operations
  • 45—External works for health buildings
  • 46—General medical practice premises
  • 47—Health records department
  • 51—Accommodation at the main entrance of a District
  • 942
  • General Hospital
  • 51 Supp 1—Miscellaneous spaces in a District General Hospital

Health Guidance Notes

  • "Safe" hot water and surface temperatures

Miscellaneous

  • Agreement for the appointment of project managers for
  • commissions for construction projects in the NHS
  • Engineering symbols and drawing conventions
  • The control of Legionellae in health care premises: a code of practice

Concode

  • Amendments Nos. 10, 11, 12

Nucleus

  • Comprehensive children's department study pack
  • Maternity wards data pack
  • Operating department engineering data pack
  • Design information—energy and water consumptions
  • Maternity department—delivery suite and neonatal unit data pack
  • Operating department data pack
  • Accident and emergency department engineering data pack
  • Nucleus News (now Newslink—Nucleus Supplement) issues 27, 28, 29

Letter from Dr. K. Jones to Mr. Martin Redmond, dated 28 October 1992: The Secretary of State for Health will have advised that your recent Parliamentary Questions will be answered directly by the Chief Executive of the relevant agencies. I give below the response for the Medicines Control Agency:

Parliamentary Question P.117

During the last 12 months I have published an Annual Report and Accounts.

Parliamentary Question P.9

I have made one fact finding visit during the last 12 months. On the 18 May I attended a Food & Drug Administration hearing in Washington, USA, to determine the point of view of the advisory panel to the FDA for the benzodiazepine, triazolam (Halcion, Upjohn Ltd.).